Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

3187

Actual shortage: 257 (8%)
Anticipated shortage: 1 (0%)
Avoided shortage: 10 (0%)
Resolved: 2919 (92%)

Discontinuation Reports

435

To be discontinued: 2 (0%)
Discontinued: 410 (94%)
Reversed: 23 (5%)

Late reports

482 (13%)

Overdue reports

11 (4%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2017-08-01 2018-05-11 17844
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2019-09-26 2019-10-04 94825
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-01-28 2021-04-08 132672
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-05-06 2021-06-10 138904
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-06-24 2021-07-15 141463
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-08-27 2021-09-23 144726
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-09-16 2022-04-21 145780
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2022-06-09 2022-06-17 162283
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2022-12-01 2022-12-15 176776
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2024-09-05 2024-09-19 236802
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2024-12-13 2025-03-13 245601
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2025-01-16 2025-02-13 247885
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2025-03-06 2025-04-24 252075
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2025-03-27 2025-04-10 253568
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2025-05-08 2025-10-02 256917
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Actual shortage 2025-10-23 2025-11-27 270218
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Actual shortage 2025-10-30 2025-11-27 270660
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2021-10-21 2021-12-17 147699
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2022-08-18 2022-12-22 167237
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2023-06-08 2023-07-05 194180

Showing 641 to 660 of 3187

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
IRINOTECAN FOR INJECTION 20MG SOLUTION Discontinued 2025-05-28 2025-05-28 258762
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
METHOTREXATE SODIUM INJECTION 25MG SOLUTION Discontinued 2025-04-25 2025-04-25 255818
METHOTREXATE SODIUM INJECTION 25MG SOLUTION Discontinued 2025-05-28 2025-05-28 258481
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191

Showing 101 to 120 of 435